Sandor Victor
SEC-identified person · CIK 1620368 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kymera Therapeutics, Inc. KYMR | Director | filed 2022–2026 |
| Abcellera Biologics Inc. ABCL | Director | filed 2026–2026 |
| Prelude Therapeutics Inc PRLD | Director | filed 2020–2026 |
| ADC Therapeutics SA ADCT | Director | filed 2024–2026 |
| Merus N.V. MRUS | Director | filed 2020–2025 |
| Array Biopharma INC ARRY | Chief Medical Officer. | filed 2014–2019 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.